Valuation: Vitrolife AB

Market Cap 15.62B 1.53B 1.4B 1.29B 1.17B 2.2B 143B 2.29B 6.18B 77.37B 5.75B 5.63B 244B P/E 2026 *
32x
P/E 2027 * 25.4x
Enterprise Value 16.38B 1.61B 1.47B 1.36B 1.22B 2.31B 150B 2.4B 6.48B 81.14B 6.04B 5.91B 256B EV / Sales 2026 *
4.67x
EV / Sales 2027 * 4.14x
Free-Float
54.39%
Yield 2026 *
0.94%
Yield 2027 * 1.12%
1 week-0.51%
Current month+1.90%
1 month+20.35%
3 months+31.36%
6 months+12.85%
Current year-14.09%
1 week 116.7
Extreme 116.7
120.5
1 month 96.3
Extreme 96.3
122.8
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
152.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
573
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 55 01/11/2026
Director of Finance/CFO 55 10/10/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Buy

Chief Operating Officer

6,470 0.0048%
6/2/26 Buy

Chief Executive Officer

3,013 0.0022%
4/2/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.51%-15.63%-33.76% 1.55B
-0.11%-4.45%-19.67%+3.19% 181B
-1.61%-0.99%-0.19%+33.85% 125B
-0.02%-0.36%-11.65%+9.80% 121B
+1.12%-0.96%-41.94%+2.39% 90.52B
-0.72%-0.57%-3.80%+77.55% 66.9B
+0.50%+0.76%+12.38%-7.50% 58.68B
+1.53%-0.37%+4.44%+48.01% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+4.77%+3.97%-1.08% 35.4B
Average +0.25%-0.56%-7.39%+17.11% 78B
Weighted average by Cap. +0.02%-1.52%-10.28%+19.61%

Financials

2026 *2027 *
Net sales 3.51B 345M 314M 291M 262M 494M 32.22B 514M 1.39B 17.39B 1.29B 1.27B 54.91B 3.83B 376M 343M 317M 286M 539M 35.12B 560M 1.51B 18.96B 1.41B 1.38B 59.86B
Net income 495M 48.58M 44.3M 40.96M 36.96M 69.62M 4.54B 72.36M 196M 2.45B 182M 178M 7.74B 620M 60.86M 55.5M 51.32M 46.31M 87.22M 5.69B 90.66M 245M 3.07B 228M 224M 9.69B
Net Debt 762M 74.78M 68.2M 63.05M 56.9M 107M 6.99B 111M 301M 3.77B 281M 275M 11.91B 225M 22.08M 20.14M 18.62M 16.81M 31.65M 2.06B 32.9M 88.9M 1.11B 82.85M 81.11M 3.52B
Projected Income Statement - Annual - Vitrolife AB
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,088
Date Price Change Volume
19/11/26 SEK 117.70 0.00% 132,716
17/11/26 SEK 117.70 -1.18% 602,419
16/11/26 SEK 119.10 -0.08% 174,285
13/11/26 SEK 119.20 +1.19% 157,094
12/11/26 SEK 117.80 -0.42% 198,434
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Vitrolife AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
117.70SEK
Average target price
133.00SEK
Spread / Average Target
+13.00%
  1. Stock Market
  2. Stocks
  3. VITR Stock